[ET Net News Agency, 29 March 2021] Pharmaron Beijing Co., Ltd. (03759) said its profit
attributable to owners of the parent was RMB1.17 billion for the year ended 31 December
2020, a year-on-year increase of 114.3%. A final dividend of RMB0.3 will be distributed.
The revenue was RMB5.13 billion, a year-on-year increase of 36.6%. (RC)